Results

Total Results: 61 records

Showing results for "fentanyl".

41. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=19
    January 01, 2024 - The authors posed as an aunt or uncle of a 16-year-old with a recent non-fatal fentanyl overdose to make

42. Weighted Frequency tables: PUF Medicare Pharmacy (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Medicare-Pharmacy.pdf
    April 01, 2021 - LIPOSOME 21641.46 0.00 2.4965E8 17.76 BUPIVACAINE-EPINEPHRINE 140553.4 0.01 2.4979E8 17.77 BUPIVACAINE-FENTANYL … 0.03 4.7332E8 33.66 FENOLDOPAM 11.64 0.00 4.7332E8 33.66 FENOPROFEN 4043.08 0.00 4.7333E8 33.66 FENTANYL … 5873297 0.42 4.792E8 34.08 FENTANYL-ROPIVACAINE 440.77 0.00 4.792E8 34.08 FERRIC CARBOXYMALTOSE

43. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=53
    January 01, 2024 - recruitment, resulting in 114 final participants with untreated OUD and HIV, with 62% positive for fentanyl

44. Shared Learning and the Drive to Improve Patient Safety: Lessons Learned from the Pittsburgh Regional Healthcare Initiative (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol3/Sirio.pdf
    June 15, 2003 - been established and implemented in three cross-cutting, high-risk areas: the safe prescribing of fentanyl

45. Weighted Frequency tables: PUF Commercial Pharmacy (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Commercial-Pharmacy.pdf
    April 01, 2021 - Cumulative Frequency Cumulative Percent BUPIVACAINE 406.71 0.00 2.269E8 19.83 BUPIVACAINE-FENTANYL … 4.7147E8 41.20 FENOFIBRIC ACID 436022.4 0.04 4.7191E8 41.24 FENOPROFEN 10981.82 0.00 4.7192E8 41.24 FENTANYL

46. Final Progress Report: Prescription Opioid Use Trajectories and Risk Factors Associated with Opioid-Related Hospitalizations in Older Adults (pdf file)
    www.ahrq.gov/sites/default/files/2024-02/wei-report.pdf
    January 01, 2024 - These opioids included butorphanol, codeine, dihydrocodeine, fentanyl, hydrocodone, hydromorphone,

47. Final Progress Report: RESPOND Pharmacy Education Toolkit: AHRQ Final Report (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/hartung-report.pdf
    January 01, 2024 - harm reduction services in community pharmacies such as naloxone, syringe exchange and disposal, and fentanyl

48. 2023 National Healthcare Quality and Disparities Report (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-nhqdr-es.pdf
    January 01, 2023 - Synthetic opioids include medications such as fentanyl and tramadol, as well as legally and illegally

49. 2023 National Healthcare Quality and Disparities Report (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-nhqdr-es-rev.pdf
    January 01, 2023 - Synthetic opioids include medications such as fentanyl and tramadol, as well as legally and illegally

50. Appendixes | Agency for Healthcare Research and Quality
    www.ahrq.gov/hai/pfp/haccost2017-appendix.html
    November 01, 2017 - Penicillamine (2,5)- "[mh] OR "Ethylketocyclazocine"[mh] OR "Ethylmorphine"[mh] OR "Etorphine"[mh] OR "Fentanyl

51. Appendixes | Agency for Healthcare Research and Quality
    www.ahrq.gov/es/hai/pfp/haccost2017-appendix.html
    November 01, 2017 - Penicillamine (2,5)- "[mh] OR "Ethylketocyclazocine"[mh] OR "Ethylmorphine"[mh] OR "Etorphine"[mh] OR "Fentanyl

52. SyH-DR PUF Summary Statistics-Medicaid Pharmacy Weighted (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Medicaid-Pharmacy.pdf
    April 01, 2021 - LIPOSOME 480.95 0.00 1.2767E8 20.91 BUPIVACAINE-EPINEPHRINE 4775.89 0.00 1.2767E8 20.91 BUPIVACAINE-FENTANYL … 2.4155E8 39.56 FENOFIBRIC ACID 86306.78 0.01 2.4164E8 39.57 FENOPROFEN 3958.32 0.00 2.4164E8 39.57 FENTANYL

53. In Situ Simulation: Challenges and Results (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol3/Advances-Patterson_48.pdf
    May 05, 2008 - PROBLEM STATE Dangerous Movement Lidocaine/insulin needles EMLA Numbey Tylenol oral, rectal NSAIDs Fentanyl

54. Final Progress Report: Opioid Stewardship in Urology (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/smith-report.pdf
    January 01, 2024 - in his own institution, using an opioid-free regimen to avoid the hyperalgesia of administered fentanyl

55. Final Progress Report: The ED Pharmacist as a Safety Measure in Emergency Medicine (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/fairbanks-report.pdf
    January 01, 2024 - 6.8%), propofol (8.8%), and 3% of each of the following: midazolam, acetaminophen, tetanus booster, fentanyl

56. Final Progress Report: The ED Pharmacist as a Safety Measure in Emergency Medicine (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/15818-Fairbanks-draft-1.pdf
    September 08, 2008 - 6.8%), propofol (8.8%), and 3% of each of the following: midazolam, acetaminophen, tetanus booster, fentanyl

57. Slide 1
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/archived-webinars/preventing-cauti-focus-procedure-related-cath-use-070814.pptx
    January 01, 2015 - local anesthetics Hydrophilic opioids (morphine) Opioids with high- receptor selectivity (morphine, fentanyl

58. Making Healthcare Safer Practices: 10. Harms Due to Opioids (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/opioids-1.pdf
    March 01, 2020 - wave in 2013 with the increase in overdoses involving synthetic opioids (e.g., illicitly manufactured fentanyl

59. Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hac-cost-report2017.pdf
    November 01, 2017 - Penicillamine (2,5)- ”[mh] OR “Ethylketocyclazocine”[mh] OR “Ethylmorphine”[mh] OR “Etorphine”[mh] OR “Fentanyl

60. Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions (pdf file)
    www.ahrq.gov/sites/default/files/publications2/files/hac-cost-report2017.pdf
    November 01, 2017 - Penicillamine (2,5)- ”[mh] OR “Ethylketocyclazocine”[mh] OR “Ethylmorphine”[mh] OR “Etorphine”[mh] OR “Fentanyl